NCT04316481 - IDE-ALERTS Continued Access Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions

Acute Coronary Syndrome

Interventions

DEVICE

AngelMed Guardian System

The AngelMed Guardian System detects potential ongoing ACS events, characterized by sustained ST segment changes, and alerts the patient to seek medical attention for those potential ACS events. The Guardian System is indicated as an adjunct to patient recognized symptoms.

Trial Locations (1)

92868

Orange County Heart Institute and Research Center, Orange